Related references
Note: Only part of the references are listed.Bone development and remodeling in metabolic disorders
Jenny Serra-Vinardell et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment
Jennifer Zarrer et al.
BIOMOLECULES (2020)
Methoxsalen and Bergapten Prevent Diabetes-Induced Osteoporosis by the Suppression of Osteoclastogenic Gene Expression in Mice
Ju Ri Ham et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties
Ann-Kristin Picke et al.
ENDOCRINE CONNECTIONS (2019)
Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts
Tan Zhang et al.
FASEB JOURNAL (2019)
Modulatory Effects of Plant Polyphenols on Bone Remodeling: A Prospective View From the Bench to Bedside
Vanessa Nicolin et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
Kamyar Asadipooya et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Bone function, dysfunction and its role in diseases including critical illness
Nan Su et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
The bone remodelling cycle
J. S. Kenkre et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2018)
Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review
Panagiotis Anagnostis et al.
ENDOCRINE (2018)
Coumarins as potential antidiabetic agents
Hanbing Li et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Molecular signaling mechanisms behind polyphenol-induced bone anabolism
Elisa Torre
PHYTOCHEMISTRY REVIEWS (2017)
The impact of type 2 diabetes on bone metabolism
Claudia Pinheiro Sanches et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Oxidative stress in bone remodeling: role of antioxidants
Vladana Domazetovic et al.
CLINICAL CASES IN MINERAL AND BONE METABOLISM (2017)
Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells
Ziqing Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Determinants of bone strength and quality in diabetes mellitus in humans
Joshua N. Farr et al.
BONE (2016)
Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
Deborah E. Sellmeyer et al.
DIABETES (2016)
Mediators of inflammation and bone remodeling in rheumatic disease
Anita T. Shaw et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Type 2 diabetes and the skeleton: new insights into sweet bones
Vikram V. Shanbhogue et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Advanced Glycation End Products, Diabetes, and Bone Strength
Masahiro Yamamoto et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
Osteoblast Differentiation at a Glance
Arkady Rutkovskiy et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2016)
Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signalregulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway
Hong-Zheng Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Fisetin antagonizes cell fusion, cytoskeletal organization and bone resorption in RANKL-differentiated murine macrophages
Yun-Ho Kim et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
Roberta Sanguineti et al.
MEDIATORS OF INFLAMMATION (2014)
Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
Gurdip Daffu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Mechanical Signaling for Bone Modeling and Remodeling
Alexander G. Robling et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice
Jung-Lye Kim et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts
Jung-Lye Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages
Jung-Lye Kim et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Disorders of Bone Remodeling
Xu Feng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Bone regeneration and stem cells
K. Arvidson et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms
Kannikar Wongdee et al.
WORLD JOURNAL OF DIABETES (2011)
Cellular and Molecular Mechanisms of Bone Remodeling
Liza J. Raggatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
High D(+)glucose concentration inhibits RANKL-induced osteoclastogenesis
Y. Wittrant et al.
BONE (2008)
Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts
Chih-Hsin Tang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The effect of thiazolidinediones on BMD and osteoporosis
Allyson K. McDonough et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Bone metabolism in male patients with type 2 diabetes
L Achemlal et al.
CLINICAL RHEUMATOLOGY (2005)
Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man
U Kornak et al.
CELL (2001)
Share Paper
